A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole
Sang Min Lee, Yong Kyun Cho, Yon Mi Sung, Dong Hae Chung, Sung Hwan Jeong, Jeong-Woong Park, Sang Pyo Lee
Korean J Parasito. 2015;53(3):321-327.   Published online 2015 Jun 30     DOI: https://doi.org/10.3347/kjp.2015.53.3.321
Citations to this article as recorded by Crossref logo
Molecular Study of Pneumocystis jirovecii in Respiratory Samples of HIV Patients in Chile
Isabel Iturrieta-González, Carolina Chahin, Johanna Cabrera, Carla Concha, Pamela Olivares-Ferretti, Javier Briones, Fernando Vega, Luis Bustos-Medina, Flery Fonseca-Salamanca
Journal of Fungi.2024; 10(2): 117.     CrossRef
Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate
Francois D. Rouleau, Alexandre K. Dubé, Isabelle Gagnon-Arsenault, Soham Dibyachintan, Alicia Pageau, Philippe C. Després, Patrick Lagüe, Christian R. Landry, Adrian Serohijos
PLOS Genetics.2024; 20(4): e1011252.     CrossRef
Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients
Atif Ibrahim, Asmi Chattaraj, Qamar Iqbal, Ali Anjum, Mohammad Ebad Ur Rehman, Zobia Aijaz, Fazila Nasir, Sadia Ansar, Tirdad T. Zangeneh, Ahmad Iftikhar
Avicenna Journal of Medicine.2023; 13(01): 023.     CrossRef
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
Thomas R Rogers, Paul E Verweij, Mariana Castanheira, Eric Dannaoui, P Lewis White, Maiken Cavling Arendrup, M C Arendrup, S Arikan-Akdagli, F Barchiesi, Jochem Buil, M Castanheira, E Chryssanthou, N Friberg, J Guinea, P Hamal, Ingibjorg Hilmarsdottir, N
Journal of Antimicrobial Chemotherapy.2022; 77(8): 2053.     CrossRef
Effectiveness of front line and emerging fungal disease prevention and control interventions and opportunities to address appropriate eco-sustainable solutions
Mary Garvey, Elaine Meade, Neil J. Rowan
Science of The Total Environment.2022; 851: 158284.     CrossRef
Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens
Ana Gomes, Ricardo Ferraz, Lauren Ficker, Margaret S. Collins, Cristina Prudêncio, Melanie T. Cushion, Cátia Teixeira, Paula Gomes
Antimicrobial Agents and Chemotherapy.2018;[Epub]     CrossRef
Therapy and Management of Pneumocystis jirovecii Infection
P. Lewis White, Jessica S. Price, Matthijs Backx
Journal of Fungi.2018; 4(4): 127.     CrossRef
Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort
Isabelle Suárez, Lisa Roderus, Edeltraud van Gumpel, Norma Jung, Clara Lehmann, Gerd Fätkenheuer, Pia Hartmann, Georg Plum, Jan Rybniker
Infection.2017; 45(3): 341.     CrossRef
Cotrimoxazole
Reactions Weekly.2016; 1583(1): 348.     CrossRef
La pneumocystose au cours de l’infection à VIH
M. El Fane, M. Sodqi, A. Oulad Lahsen, A. Chakib, L. Marih, K. Marhoum El Filali
Revue de Pneumologie Clinique.2016; 72(4): 248.     CrossRef
Managing the oncologic patient with suspected pneumonia in the intensive care unit
D. Leoni, B. Encina, J. Rello
Expert Review of Anti-infective Therapy.2016; 14(10): 943.     CrossRef
A Case of Pneumonia Caused byPneumocystis jiroveciiResistant to Trimethoprim/Sulfamethoxazole in the Absence of Previous Drug Exposure
Ari Ahn, Jeonghyun Chang, Heungsup Sung, Mi-Na Kim
Laboratory Medicine Online.2016; 6(4): 250.     CrossRef